PAFAH1B1 and Lissencephaly: Although further experimental validation into the precise function of the regions affected by these variants is needed, this study establishes a solid foundation to understand the molecular basis of LIS1 contribution in lissencephaly such as brain disorders, which can be a solid foundation for further research into targeting the LIS1 with therapeutics as a possible treatment for early brain developmental genetic disorders.